Relapsing infection due to Enterobacter species: lessons of heterogeneity.
Medeiros
A A
AA
D000038:Abscess / Q000188:drug therapy; D016470:Bacteremia / Q000188:drug therapy; D000077723:Cefepime; D002439:Cefotaxime / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D018550:Cephalosporin Resistance; D002511:Cephalosporins / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D004754:Enterobacter / Q000187:drug effects*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D006801:Humans; D009154:Mutation; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000235:genetics
D002511:Cephalosporins; D000077723:Cefepime; D002442:Ceftazidime; D001618:beta-Lactamases; D002439:Cefotaxime